Regenerex Pharma (RGPX) Current Leases (2023 - 2025)

Regenerex Pharma (RGPX) has 3 years of Current Leases data on file, last reported at $191181.0 in Q3 2025.

• Current Leases for Q3 2025 came in at $191181.0, up 14.96% year-over-year; the trailing twelve-month figure through Sep 2025 was $191181.0 (up 14.96% YoY), and the FY2025 annual result was $181894.0, up 41.81% from the prior year.
• Current Leases rose to $191181.0 in Q3 2025 per RGPX's latest filing, from $167673.0 in the prior quarter.
• Over five years, Current Leases peaked at $191181.0 in Q3 2025 and troughed at $128264.0 in Q1 2024.
• A 3-year average of $163822.5 and a median of $166990.5 in 2024 frame the typical range for Current Leases.
• On a YoY basis, Current Leases climbed as much as 41.81% in 2025 and fell as far as 3.78% in 2025.
• A 3-year view of Current Leases shows it stood at $152046.0 in 2023, then climbed by 16.69% to $177422.0 in 2024, then grew by 7.75% to $191181.0 in 2025.
• Business Quant data shows RGPX's Current Leases at $191181.0 in Q3 2025, $167673.0 in Q2 2025, and $181894.0 in Q1 2025.